We are live on
!
Find out more
ACM
Alethea Capital Management Portfolio holdings
AUM
$195M
1-Year Est. Return
51.17%
This Fund
S&P 500
This Quarter
Est. Return
+9.1%
1 Year Est. Return
+51.17%
3 Year Est. Return
+200.24%
5 Year Est. Return
+277.75%
10 Year Est. Return
+2,049.08%
AUM
$132M
AUM Growth
+$8.68M
(+7.1%)
Cap. Flow
+$230K
Cap. Flow
% of AUM
0.17%
Top 10 Holdings %
Top 10 Hldgs %
94.1%
Holding
52
New
20
Increased
4
Reduced
2
Closed
21
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
|
+$10.9M |
| 2 |
Synchrony
SYF
|
+$528K |
| 3 |
BNY
Bank of New York Mellon
BNY
|
+$520K |
| 4 |
Extra Space Storage
EXR
|
+$506K |
| 5 |
Mondelez International
MDLZ
|
+$502K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
RNAM
Avidity Biosciences
RNAM
|
+$7.38M |
| 2 |
Vanguard Small-Cap Growth ETF
VBK
|
+$2.08M |
| 3 |
Invesco S&P 500 Equal Weight Utilities ETF
RSPU
|
+$645K |
| 4 |
Diamondback Energy
FANG
|
+$598K |
| 5 |
Allstate
ALL
|
+$578K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 67.18% |
| 2 | Financials | 1.56% |
| 3 | Consumer Staples | 1.24% |
| 4 | Real Estate | 1.08% |
| 5 | Consumer Discretionary | 1.01% |
Similar funds
WM
LWA
CPI
WAL
NLWP
ICMARC
RAM
MHFA
Alethea Capital Management's Q2 2024 Portfolio in Review
As of Q2 2024, Alethea Capital Management held 52 positions worth $132M, up 7.1% from $123M the previous quarter. Its ten largest holdings account for 94% of the portfolio.
Alethea Capital Management's Q2 2024 filing shows 20 new, 4 increased, 2 reduced and 21 closed positions. Its largest new stake was Synchrony: 12,156 shares worth $574K. The largest sale was Avidity Biosciences, an estimated $7.38M.
By sector, the portfolio is most concentrated in Healthcare at 67% of assets, down from 70% a quarter earlier, followed by Financials and Consumer Staples.
- Alethea Capital Management's largest Q2 2024 buy was Synchrony: 12,156 shares worth $574K.
- Alethea Capital Management added most to State Street SPDR Bloomberg 1-3 Month T-Bill ETF in Q2 2024, an estimated $10.9M increase.
- Alethea Capital Management's biggest Q2 2024 reduction was Avidity Biosciences, cutting an estimated $7.38M.
- Alethea Capital Management fully exited Vanguard Small-Cap Growth ETF in Q2 2024, selling an estimated $2.08M.
- Alethea Capital Management's ten largest holdings make up 94% of its $132M portfolio in Q2 2024.
- Alethea Capital Management opened 20 new positions and closed 21 in Q2 2024.
- Alethea Capital Management's portfolio value rose 7.1% quarter-over-quarter to $132M.
Based on Alethea Capital Management's 13F filing for Q2 2024, filed 15 Aug 2024.